Telepathology solutions: Designing diagnostic infrastructure for modern healthcare

• Advances in telepathology and digital pathology solutions shorten the distance between patients awaiting a diagnosis and the specialists capable of providing it

• Two predominant structural approaches to adopting telepathology have emerged, both focused on removing geographical barriers to expertise, and designing systems capable of scaling

• Well-designed telepathology solutions can bring value to healthcare systems by reducing turnaround times, easing pressure on staff, and strengthening equitable access to diagnostic care

During my pathology residency, I remember a patient who arrived carrying his histology slides carefully protected for review. He had spent nearly a month gathering the resources needed to travel. After arriving, he waited an additional two weeks for the results. The journey back to his hometown would take several more days, and securing a new appointment with his physician would require, in the best-case scenario, another one to two weeks. In total, nearly two months.

Two months without a definitive diagnosis.

Two months without initiating treatment.

Two months of uncertainty in an oncologic context.

Now, in the era of digital pathology, telepathology and whole slide imaging solutions eliminate the need for physical slide transport, which means diagnostic cycles can be shortened, and therapeutic decisions can be accelerated.

Pathology has always been the foundation of clinical decision-making. Today, telepathology allows that foundation to extend beyond the walls of a single institution and across health systems. Two predominant structural approaches have emerged to enable this expansion of services.

One model, often described as hub-and-spoke, concentrates subspecialized expertise in reference centers while peripheral institutions digitize and transmit cases for interpretation.¹ Programs such as GLORIA in Colombia demonstrate how this structure can connect regional laboratories with oncology centers of excellence, reducing geographic barriers and strengthening access to specialized expertise.¹ The objective is not to centralize authority, but to extend diagnostic capacity. In practice, this model enables institutions to:

• Concentrate expertise without requiring physical relocation

• Reduce risks associated with specimen transport

• Improve access to second opinions

• Optimize turnaround times in complex cases

Other systems have adopted a more distributed approach, interconnecting multiple institutions that share a diagnostic workload in real time.² In Japan, the Nagasaki-Kameda digital network links academic and regional hospitals to dynamically manage case volume.³ In Quebec, Canada, a network integrating 18 hospitals has ensured intraoperative consultation coverage in centers without an on-site pathologist, eliminating service interruptions.^4,5 Here, strength does not reside in a single center, but in system-wide interconnectivity. This structure enables:

• Dynamic case redistribution during demand surges

• Operational continuity despite local staffing shortages

• Greater resilience during unexpected disruptions

• Improved retention of specialists in rural settings

For both structural approaches, the underlying principle remains the same: decouple expertise from geography and design systems capable of scaling.

Telepathology is not adopted simply because the technology exists, but when it generates trust. In medicine, trust is demonstrated through validation under real-world conditions. The most successful health systems understand this, and incorporate processes to enable safe and scalable adoption, such as:^6,7

• Consistent diagnostic concordance between glass slides and digital interpretation

• Validation using an appropriate case volume for each clinical application

• Assessment within the same technical environment that will be used in routine practice

In pharmaceutical development and multicenter clinical trials, governance takes on an even more strategic dimension. Responsible implementation can be understood through a structured three-level framework, often referred to as V3:⁸

• Technical verification: Confirming that image capture and storage are robust and reproducible.

• Analytical validation: Ensuring that measurements derived from digital images are consistent and reliable.

• Clinical validation: Demonstrating that those measurements provide meaningful clinical value when informing diagnostic or therapeutic decisions.

Institutions that structure their validation processes rigorously not only reduce medico-legal risk and facilitate regulatory audits, they also build credibility, strengthen internal confidence, and create a secure foundation for the responsible integration of digital pathology applications.

When institutions first consider telepathology, the conversation tends to start in the same place: hardware costs, storage requirements, infrastructure upgrades. This is a reasonable starting point, but it is also a limiting one. Digital pathology generates more than just efficiency, it generates capital across four dimensions, with each one building on the last: ^9-12

1. Operational capital is the most visible. When slides no longer need to travel physically, the logistics that once defined diagnostic timelines simply disappear. Complex cases reach subspecialists in hours rather than weeks. Second opinions stop being a bureaucratic exercise. Turnaround times improve, workloads become more manageable, and the system gains a flexibility it didn't have before, without necessarily adding headcount.

2. Human capital runs deeper. One of the quieter consequences of digital pathology is what it does to geography. A hospital in a rural or peripheral setting no longer has to accept a lower standard of diagnostic expertise simply because of where it is located. Through network-based collaboration and remote review, teams in underserved areas can access the same level of consultation as major academic centers. That matters for the specialists too, distributed workloads reduce the kind of sustained pressure that leads to burnout, and coverage no longer depends on physically moving people to where the need is.

3. Scientific and data capital reflects a more fundamental shift in what a digital image actually is. In an analog workflow, a slide is reviewed and filed. In a digital one, it becomes a structured asset, available for audit, AI model training, digital pathology research, biomarker research, and participation in translational studies that would otherwise be out of reach. When images can be shared, annotated, and discussed across institutions in real time, diagnosis itself changes character. It becomes less of a solitary judgment and more of a collective process, where precision is distributed rather than concentrated in a single expert.

4. Strategic capital is perhaps the hardest to quantify, but not the hardest to understand. Institutions that build consolidated digital infrastructure don't just work better internally, they become more relevant externally. They are better positioned to participate in multicenter trials, to serve as centralized review hubs for complex cases, to function as meaningful nodes within precision medicine networks. Digital capability, over time, becomes part of how an institution is seen and where it sits within the broader landscape of healthcare.

Healthcare systems don't operate in stable conditions. Specialist shortages, rising diagnostic volumes, growing subspecialization, and global disruptions aren't emerging challenges; they are the baseline.^13,14 In this context, telepathology is not a technological upgrade but a mechanism for maintaining functionality when the system is under pressure. It is for this reason that most advanced health systems are already embracing telepathology solutions.

By redistributing cases across institutions and maintaining coverage during absences, health systems can absorb demand surges without compromising diagnostic quality. This flexibility replaces traditional operational rigidity, ensuring a resilient infrastructure that protects patient care even during peak pressure.

That said, technology doesn't transform anything on its own. Real adoption requires institutional leadership, interoperability between systems, serious cybersecurity, and the kind of change management that actually accompanies professionals through the transition rather than just announcing it.^15,16 Implementations that stop at equipment acquisition without an organizational vision behind them tend to fall apart quietly.¹⁷ Those that treat telepathology as infrastructure, rather than just a tool, build something that lasts.

Telepathology doesn't replace the pathologist. It doesn't reduce diagnosis to an algorithm. It is an essential structural evolution that diagnostic systems need in order to operate at the speed, scale, and complexity that medicine now demands.